Galectin Therapeutics
GALT
GALT
43 hedge funds and large institutions have $2.79M invested in Galectin Therapeutics in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $3.43M → $2.79M (-$639K)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
43
Holding in Top 10
–
Calls
$86K
Puts
$23K
Top Buyers
| 1 | +$119K | |
| 2 | +$78.3K | |
| 3 | +$31K | |
| 4 |
LWAC
Laurel Wealth Advisors (California)
Solana Beach,
California
|
+$9K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.32K |
Top Sellers
| 1 | -$158K | |
| 2 | -$99K | |
| 3 | -$61.4K | |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
-$41.4K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$35K |